Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032390	u-jcvnh	— (—)	203	781	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

143

143.86

284.55

4.2

2.7

—

L04AA Selective immunosuppressants

134

123.53

264.32

4.0

2.5

—

Renal failure

147

104.07

262.67

4.2

3.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

173

65.49

224.34

4.0

2.4

—

Dental caries

107

106.84

206.08

4.6

1.7

—

ILD medications: immunosuppressive drugs

185

255.55

177.85

4.0

1.0

—

Renal tubulo-interstitial diseases

145

27.87

176.00

3.8

3.7

—

L04AD Calcineurin inhibitors

171

298.48

169.08

4.0

6.8

—

First line medication for Crohn's disease

161

54.99

167.51

4.4

2.0

—

Glomerular diseases

46.77

165.58

4.2

4.4

—

Nephropathy related operations

153

263.51

150.22

4.3

3.0

—

Kidney transplant status

145

261.09

143.26

4.3

3.0

—

Dialysis, with operation codes

146

250.40

142.92

4.1

3.0

—

Azathioprine

36.51

133.27

5.5

3.7

—

ILD medications

175

106.96

128.11

4.2

1.0

—

Dentofacial anomalies [including malocclusion]

68.57

125.17

6.7

1.7

—

Other diseases of hard tissues of teeth

103

28.51

123.09

5.6

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

162

114.66

120.75

4.2

1.0

—

Molar incisor enamel hypoplasia

40.10

117.32

6.7

6.2

—

Glomerulonephritis

43.85

115.84

5.3

5.4

—

L04AX Other immunosuppressants

16.89

115.80

5.2

2.6

—

Second line medication for Crohn's disease

16.49

115.61

5.3

2.5

—

Hypoplasia of dental enamel, including avohilmo

54.10

114.41

6.8

6.2

—

Persons encountering health services for specific procedures and health care

134

14.85

110.98

3.7

—

Hypoplasia of dental enamel , including avohilmo

38.27

110.13

6.8

6.1

—

Care involving dialysis

111

143.90

104.81

3.9

3.8

—

Acute tubulo-interstitial nephritis

24.52

103.96

4.0

3.5

—

Nephrotic syndrome

55.45

101.91

5.9

6.7

—

Fever of other and unknown origin

18.37

101.62

3.9

2.1

—

Septicaemia

16.77

85.57

4.2

4.6

—

Hypertensive diseases (excluding secondary)

20.29

83.61

5.1

3.8

—

Other septicaemia

17.42

83.44

4.1

4.7

—

Antihypertensive medication - note that there are other indications

102

18.04

83.30

5.3

3.5

—

Other disorders of kidney and ureter

48.45

82.25

4.1

4.4

—

Explicit Sepsis

15.26

81.47

4.2

4.7

—

Hypertension

103

14.60

79.50

4.7

3.0

—

Hypertensive diseases

103

14.24

78.68

4.7

3.1

—

Other bacterial diseases

106

9.79

75.57

3.8

3.7

—

Any gastric operation

37.45

74.88

4.2

2.2

—

GASTRO-related operations

37.45

74.88

4.2

2.2

—

Other problems related to primary support group, including family circumstances

16.78

74.29

7.1

4.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

10.01

74.00

4.7

3.1

—

Cardiovascular diseases (excluding rheumatic etc)

101

12.43

73.53

4.9

4.2

—

Genitourinary diseases

19.47

72.81

5.8

3.5

—

Extracorporeal dialysis

94.40

66.31

3.5

4.8

—

Dentinal caries

90.18

64.79

3.7

1.9

—

Intestinal infectious diseases

8.22

64.07

4.1

2.9

—

Viral and other specified intestinal infections

14.72

63.03

5.8

4.2

—

Congenital malformations of the urinary system

17.97

62.89

4.3

6.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

11.32

61.98

6.9

3.5

—

Bacterial infection, other or unspecified

13.67

59.86

3.8

3.6

—

Other disorders of gingiva or/and edentulous alveolar ridge

+∞

59.68

6.5

0.0

—

Cardiovascular diseases

10.91

59.03

5.1

4.4

—

Gingival hyperplasia

+∞

58.82

6.6

0.0

—

Direct fill therapy

13.14

58.76

4.8

5.7

—

Viral infections characterized by skin and mucous membrane lesions

9.34

57.88

4.4

—

Other dialysis

85.18

57.65

4.9

4.8

—

Anaemias

30.93

56.72

4.4

4.2

—

Heart failure, not strict

11.56

56.62

2.4

4.0

—

Inflammatory bowel disease treatment related agents

106

7.26

55.11

4.8

2.6

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6.95

52.15

3.9

3.7

—

Diseases of oral cavity, salivary glands and jaws

13.88

51.50

5.2

1.4

—

Molar incisor enamel hypoplasia, with caries

76.22

49.44

6.6

8.1

—

Aplastic and other anaemias

12.25

48.01

3.5

3.3

—

Diseases of pulp and periapical tissues

24.66

45.13

1.8

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

14.86

45.02

3.3

5.8

—

Certain infectious and parasitic diseases

11.92

44.75

3.9

2.3

—

Metabolic disorders

7.07

44.44

2.7

4.2

—

Acute upper respiratory infections of multiple and unspecified sites

8.25

43.83

4.1

2.6

—

Primary_lymphoid and hematopoietic malignant neoplasms

13.84

43.31

3.3

5.3

—

Gastrointestinal diseases

20.84

43.17

4.5

1.4

—

Excessive attrition of teeth

17.68

41.95

6.4

1.6

—

Other viral diseases

7.41

41.73

5.4

4.1

—

Erosion of teeth, including avohilmo

28.09

41.66

5.8

1.3

—

Care involving use of rehabilitation procedures

9.70

41.25

3.6

4.0

—

Disorders resulting from impaired renal tubular function

77.88

40.16

4.1

4.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.50

39.48

4.2

5.9

—

Implicit viral Sepsis

17.28

37.61

3.5

4.9

—

Viral Sepsis

17.28

37.61

3.5

4.9

—

Congenital malformations, deformations and chromosomal abnormalities

6.30

37.17

3.5

4.1

—

Implicit Sepsis

7.78

36.26

2.8

3.8

—

Viral warts

16.78

35.82

5.3

5.1

—

Bacterial Sepsis

12.09

35.63

3.0

4.0

—

Glomerular disorders in diseases classified elsewhere

52.95

35.40

2.1

3.0

—

Other disorders of fluid, electrolyte and acid-base balance

17.05

35.35

3.4

4.4

—

Implicit bacterial Sepsis

14.43

34.72

2.7

3.4

—

Anomalies of dental arch relationship, including avohilmo

9.23

34.72

6.8

4.1

—

General examination and investigation of persons without complaint and reported diagnosis

12.11

34.10

5.0

1.4

—

Hypoplasia of dental enamel, prenatal , including avohilmo

24.51

33.59

8.0

6.6

—

Any reimbursement code in KELA

38.00

33.25

3.6

1.6

—

Influenza and pneumonia

113

4.89

32.98

3.8

—

7.58

32.97

3.7

2.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.58

32.97

3.7

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

6.91

32.46

2.8

3.7

—

Infections, IBD-co-morbidities

16.86

29.29

2.9

5.0

—

Cystic kidney disease

67.75

29.04

3.0

4.0

—

Other viral diseases, not elsewhere classified

6.53

27.94

5.9

4.5

—

Other reaction to severe stress, and adjustment disorders

7.61

27.13

3.6

3.0

—

Diabetic nephropathy

61.50

26.78

1.1

1.2

—

Nausea and vomiting

6.68

26.51

5.1

5.0

—

Other and unspecified anaemias

8.88

26.26

3.4

—

Bronchitis

5.34

26.26

3.6

2.2

—

Other anaemias

8.86

26.18

3.4

—

Dental caries 2 and operation codes

5.30

25.93

4.8

2.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.52

25.83

3.8

—

General symptoms and signs

5.87

25.57

3.2

1.9

—

Dental caries 2

5.15

25.51

4.6

2.9

—

Other retinal disorders

7.65

25.35

1.6

2.5

—

Disorders of other endocrine glands

5.43

25.17

5.0

4.9

—

Diseases of peritoneum

58.38

24.99

3.5

2.0

—

Other disorders of urethra and urinary system

6.39

24.90

4.0

3.1

—

Zoster [herpes zoster]

16.20

24.55

2.2

2.7

—

Other metabolic disorders

14.72

24.49

3.2

3.4

—

Provisional assignment of new diseases of uncertain etiology

6.22

24.37

3.6

4.0

—

Codes for special purposes

6.22

24.37

3.6

4.0

—

Pneumonia, organism unspecified

103

4.50

23.87

4.0

—

Pneumonias (Asthma/COPD co-morbidities)

118

4.17

23.80

3.8

4.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

9.44

23.79

4.0

1.4

—

All influenza

7.82

23.37

4.4

4.5

—

Insulin, fast-acting (human)

12.14

22.95

1.2

2.8

—

Certain disorders involving the immune mechanism

9.06

22.94

5.0

3.7

—

Examination and observation for other reasons

9.85

22.65

4.3

1.2

—

Crowding of teeth, including avohilmo

6.72

22.38

7.1

5.2

—

Diabetic retinopathy, strict definition

15.41

22.13

1.2

—

All pneumoniae

125

3.92

22.02

3.8

4.0

—

Hypoplasia of dental enamel, prenatal

56.41

21.82

8.0

6.3

—

Acute suppurative otitis media

6.29

21.68

5.2

4.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

4.81

21.66

5.5

4.3

—

Complications of medical and surgical care

5.47

21.52

2.8

2.9

—

Otitis media, unspecified

7.55

21.17

4.8

5.2

—

Complications of surgical and medical care, not elsewhere classified

4.54

20.70

2.7

3.0

—

Acute upper respiratory infections

4.83

20.66

4.2

2.4

—

Endocrine, nutritional and metabolic diseases

4.51

20.08

3.7

4.8

—

Covid-19 confirmed case

7.26

19.89

3.2

—

Hyperlipidaemia, other/unspecified

15.50

19.86

1.5

1.7

—

Medical observation and evaluation for suspected diseases and conditions

8.39

19.63

3.2

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

127

3.71

19.45

3.9

—

Headache

6.57

19.25

3.8

2.1

—

Persons encountering health services in other circumstances, wide

3.84

19.24

3.5

3.8

—

Disorders of lens

6.89

19.15

3.0

2.1

—

Other cataract

10.33

18.90

4.0

2.8

—

Chronic periapical parodontitis

34.37

18.86

1.4

1.6

—

Hypertension, essential

7.40

18.66

1.4

1.5

—

Disorders of choroid and retina

5.40

18.29

1.6

2.3

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

14.84

17.66

6.6

6.4

—

Polyneuropathies and other disorders of the peripheral nervous system

10.58

17.32

2.1

3.2

—

Unspecified haematuria

7.43

17.03

4.5

2.8

—

Other disorders of skin and subcutaneous tissue

4.99

16.99

2.6

3.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.72

16.98

2.8

3.0

—

Symptoms and signs involving the urinary system

4.48

16.83

3.9

3.4

—

Agranulocytosis

13.38

16.79

5.1

3.5

—

Nonsuppurative otitis media

5.96

16.76

4.7

—

Other and unspecified polyneuropathies, also in other diseases

15.03

16.75

1.7

2.5

—

Diabetic retinopathy

10.12

16.60

1.3

—

Hypermetropia

7.72

16.55

6.4

6.3

—

Gingivitis and periodontal diseases

7.02

16.53

3.6

1.4

—

Speech and linguistic disorders, excluding more controls

6.84

16.48

6.7

5.3

—

Other heart diseases

5.78

16.42

4.2

—

Other bacterial intestinal infections

12.33

16.02

2.4

3.8

—

Certain conditions originating in the perinatal period

5.26

15.81

5.6

5.3

—

Suppurative and unspecified otitis media

4.93

15.70

5.1

3.7

—

COPD/asthma/ILD related infections

4.70

15.18

3.8

2.4

—

COPD/asthma related infections

4.70

15.18

3.8

2.4

—

Persons encountering health services for examination and investigation

7.07

14.91

3.5

1.4

—

4.17

14.89

3.9

2.3

—

Melanocytic naevi

7.51

14.82

3.2

3.6

—

Neoplasms

3.52

14.53

3.8

4.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

27.27

14.26

2.3

2.1

—

Disorders of refraction and accommodation

4.37

14.13

6.3

4.7

—

Lack of expected normal physiological development

20.71

14.05

5.5

4.9

—

Disorders of lipoprotein metabolism and other lipidaemias

5.00

13.99

1.4

2.4

—

Oedema, not elsewhere classified

9.96

13.92

2.8

1.8

—

Heart failure,strict

9.02

13.88

3.5

4.0

—

Symptoms and signs concerning food and fluid intake

23.80

13.76

7.2

4.5

—

Deep bite

4.77

13.74

6.6

5.6

—

Other diseases of urinary system

3.44

13.42

3.8

3.4

—

Need for other prophylactic measures

13.08

13.37

6.8

6.9

—

4.74

13.37

6.7

6.4

—

Other acute lower respiratory infections

105

3.73

13.29

4.5

4.1

—

Heart failure and antihypertensive medication

26.44

13.19

3.5

1.0

—

Diabetic retinopathy, excluding more controls

18.55

13.07

1.3

—

Convulsions, not elsewhere classified

8.40

13.04

5.2

3.1

—

Anxiety disorders, excluding more controls

3.92

13.00

4.1

2.3

—

Rare circulating lymphoid malignancy

10.89

12.87

4.5

6.3

—

Hypo-osmolality and hyponatraemia

22.48

12.85

3.4

3.9

—

Type 1 diabetes

4.33

12.80

1.5

5.3

—

Diseases of the eye and adnexa

3.57

12.77

4.1

4.2

—

Persons with potential health hazards related to communicable diseases

104

3.72

12.75

4.8

4.9

—

Diseases of middle ear and mastoid

3.94

12.72

4.4

3.2

—

Cytomegalovirus infection, IBD co-morbidity

32.62

12.61

3.4

4.4

—

Neurotic, stress-related and somatoform disorders

100

3.41

12.58

3.9

2.7

—

Anxiety disorders

100

3.40

12.51

3.9

2.7

—

Sub-endpoint used in defining T1D endpoints

4.26

12.51

1.5

5.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

20.06

12.44

1.7

2.4

—

Tooth eruption problems

4.87

12.42

5.0

4.6

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

10.11

12.25

4.5

6.1

—

Gout

10.64

12.16

1.7

1.3

—

Peripheral artery disease

8.56

12.02

1.1

1.3

—

Personal history of other diseases and conditions

26.62

12.00

4.9

1.8

—

Volume depletion

10.87

11.96

3.8

4.6

—

Osteopathies and chondropathies

4.31

11.80

2.9

3.6

—

Melanocytic naevi

5.84

11.78

3.2

—

Invasive ventilation

12.05

11.74

6.3

5.0

—

Gout, FINNGEN

9.34

11.65

1.7

1.3

—

4.57

11.64

7.1

6.5

—

Other disorders starting during childhood or adolecense, excluding more controls

5.83

11.55

8.3

5.5

—

Coagulation defects, purpura and other haemorrhagic conditions

5.69

11.46

3.7

4.8

—

Bacterial intestinal infections, IBD co-morbidities

7.63

11.41

2.4

3.9

—

Infections of the skin and subcutaneous tissue

119

3.35

11.23

4.0

4.2

—

Melanocytic naevi of trunk

10.93

11.06

3.0

2.5

—

Other diseases of blood and blood-forming organs, wide

5.95

10.84

5.2

3.6

—

Cough

3.92

10.82

4.7

4.6

—

Crossbite

4.29

10.81

6.0

6.3

—

Lymphoid leukaemia

9.34

10.77

4.8

5.9

—

Lymphoid leukaemia

9.34

10.77

4.8

6.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

18.03

10.74

6.4

6.6

—

Other disorders involving the immune mechanism, not elsewhere classified

18.01

10.74

6.4

6.6

—

Insulin, fast-acting or short human

4.03

10.63

1.4

5.2

—

Insulin, fast-acting

4.03

10.63

1.4

5.2

—

Malignant neoplasm, wide definition for exclusion

3.12

10.59

3.0

3.7

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3.12

10.59

3.0

3.7

—

Acute bronchiolitis

4.04

10.30

5.5

5.9

—

All influenza (not pneumonia)

6.31

10.26

5.1

5.0

—

Statin medication

4.35

10.22

1.8

2.3

—

Erysipelas

5.78

10.21

1.3

—

11.02

10.16

2.2

1.8

—

Other endocrine disorders

4.41

10.11

6.1

6.7

—

Disorders of psychological development

3.74

10.06

6.2

5.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3.05

10.06

3.0

3.7

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.50

9.70

6.1

4.7

—

Other pulmonary diagnosis

4.42

9.60

3.1

2.1

—

Other medical care

6.66

9.43

3.1

3.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

9.38

3.4

0.0

—

Varicella [chickenpox]

8.62

9.35

4.0

5.2

—

Mycoses

5.14

9.34

3.1

3.5

—

Other disorders of teeth and supporting structures

21.69

9.34

2.8

1.7

—

Disorders of parathyroid gland

21.42

9.27

2.0

—

Senile cataract

6.20

9.26

1.2

1.4

—

8.69

9.18

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6.03

9.13

1.8

3.5

—

Dermatitis

3.49

9.03

4.1

3.4

—

Bleeding

3.06

9.03

2.5

3.8

—

Acute sinusitis

4.46

9.01

3.1

2.0

—

Actinic keratosis

9.50

8.98

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

4.27

8.96

3.1

2.1

—

Other and unspecified dermatitis

3.83

8.93

4.4

3.6

—

Vitreous haemorrhage

24.05

8.90

1.2

1.0

—

Malignant neoplasm

2.93

8.90

3.1

3.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

7.28

8.85

5.9

6.9

—

Hyperparathyroidism

23.74

8.84

2.0

1.2

—

Type 1 diabetes, wide definition

3.77

8.74

1.4

5.4

—

Heart failure, strict

4.97

8.44

3.5

2.7

—

Candidiasis

7.51

8.41

3.6

4.4

—

Acute pharyngitis

5.49

8.40

6.4

3.5

—

Skin changes due to chronic exposure to nonionizing radiation

8.68

8.40

1.0

1.1

—

Malaise and fatigue

5.17

8.38

2.3

2.5

—

Hernia

103

2.83

8.36

5.0

3.4

—

Otitis externa

4.45

8.35

6.0

4.1

—

Venous thromboembolism

5.16

8.32

1.7

1.2

—

Other and unspecified tonsillitis

4.24

8.25

4.6

2.8

—

Atherosclerosis, excluding cerebral and coronary sclerosis

7.42

8.21

1.1

1.3

—

Type 1 diabetes, wide definition, subgroup 1

3.81

8.21

1.1

5.3

—

Irregular menses

4.64

8.20

2.0

1.8

—

Dental pulpitis 2

3.69

8.15

4.5

4.3

—

Neurological diseases, wide definition

4.64

8.11

4.6

4.7

—

Immunodeficiencies

9.14

8.09

3.1

4.5

—

Dental caries 1 and operation codes

3.22

8.07

4.4

3.4

—

COPD differential diagnosis

4.01

8.06

3.2

2.3

—

ILD differential diagnosis

4.01

8.06

3.2

2.3

—

Symptoms and signs involving the digestive system and abdomen

100

2.61

7.95

4.7

3.9

—

All-cause Heart Failure

4.89

7.91

3.6

2.8

—

Diseases of arteries, arterioles and capillaries

4.09

7.90

1.0

1.9

—

Other disorders of bone

5.36

7.72

3.5

2.9

—

Childhood asthma (age<16)

6.89

7.71

3.2

3.5

—

Childhood asthma (age<16), excluding more controls

6.88

7.70

3.2

3.5

—

Speech and linguistic disorders

3.43

7.57

6.7

6.1

—

Tramadol

3.83

7.52

1.6

1.2

—

Type 2 diabetes, wide definition

3.68

7.48

1.2

1.3

—

Any event in cancer register

2.74

7.43

3.1

3.3

—

Melanocytic naevi of trunk

13.36

7.37

3.0

3.2

—

Oxycodone

5.99

7.37

1.7

1.0

—

Otitis externa, unspecified

5.92

7.37

5.5

4.6

—

Glaucoma

5.02

7.35

1.5

1.6

—

Diabetic neuropathy

13.29

7.35

1.1

1.2

—

Retinal haemorrhage

+∞

7.30

1.9

0.0

—

Non-ischemic cardiomyopathy

6.28

7.23

4.8

3.4

—

Dental operations

4.89

7.22

3.0

1.3

—

Hyperkinetic disorders, excluding more controls

5.04

7.16

6.3

5.2

—

Bacterial, viral and other infectious agents

7.71

7.12

6.1

4.5

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.64

7.02

8.0

5.7

—

Cerebrovascular diseases (FINNGEN)

7.16

7.00

2.6

1.4

—

Other strabismus

3.60

6.98

5.5

5.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.12

6.92

2.3

1.3

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

13.77

6.88

2.2

3.8

—

Symptoms and signs involving the skin and subcutaneous tissue

102

2.93

6.87

3.6

3.7

—

Cystitis

2.93

6.84

3.3

3.5

—

Recurring oral aphthae, including avohilmo

5.43

6.76

5.9

4.2

—

Noninflammatory disorders of female genital tract

4.58

6.71

2.8

2.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.73

6.60

3.6

1.8

—

Viral pneumonia

5.72

6.58

2.7

4.6

—

Distal bite

4.01

6.56

8.1

5.8

—

Dental pulpitis 2, only avohilmo

3.20

6.54

4.6

4.0

—

Short stature, not elsewhere classified

3.73

6.48

5.8

6.9

—

Insulin, intermediate and long-acting

3.07

6.46

1.2

4.4

—

Pain, not elsewhere classified

6.11

6.42

2.4

2.3

—

Strabismus

3.12

6.40

5.1

—

Enterocolitis due to Clostridium difficile

14.31

6.39

2.7

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.88

6.35

1.4

4.3

—

Other benign neoplasms of skin

5.10

6.31

2.1

3.1

—

Rash and other nonspecific skin eruption

6.68

6.31

5.0

5.2

—

Dental caries, including avohilmo

3.05

6.29

4.5

3.8

—

Dental caries 1

3.05

6.29

4.5

3.8

—

Disorders of skin appendages

3.09

6.29

4.0

3.4

—

Other diseases of arteries and capillaries

18.04

6.26

1.1

1.8

—

Acute nephritic syndrome

+∞

6.26

3.5

0.0

—

Opioids

3.01

6.24

1.7

1.8

—

Intermittent heterotropia

4.43

6.23

5.7

6.7

—

Other heart diseases, wide

125

2.33

6.22

3.8

—

Cellulitis

3.96

6.16

4.2

4.3

—

Diseases of external ear

3.39

6.12

5.9

4.1

—

Recurring oral aphthae

12.56

6.08

6.7

4.8

—

Cutaneous abscess, furuncle and carbuncle

4.11

6.08

3.2

3.5

—

Speech therapy

4.52

5.97

3.6

3.3

—

Overjet

3.90

5.96

7.8

6.2

—

Peripheral arterial reconstruction

15.01

5.90

1.1

1.0

—

Nutritional anaemias

3.41

5.86

4.0

3.3

—

Other congenital malformations of the digestive system

3.68

5.86

5.9

6.7

—

Disorders of sclera, cornea, iris and ciliary body

3.19

5.85

1.8

3.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

118

2.27

5.81

2.7

4.3

—

Benign neoplasms

2.64

5.79

3.1

3.8

—

Disorders of vitreous body

4.42

5.79

1.2

1.4

—

Hypothyroidism (congenital or acquired)

8.30

5.66

2.5

4.3

—

Other disorders starting during childhood or adolescence

3.22

5.64

8.3

5.9

—

Autoimmune diseases excluding thyroid diseases

120

2.22

5.56

2.7

4.3

—

Disorders of vitreous body and globe

4.27

5.54

1.2

1.7

—

Insulin medication

2.67

5.48

1.4

4.3

—

Immunodeficiency with predominantly antibody defects

16.12

5.41

3.6

6.2

—

Abnormal findings on examination of urine, without diagnosis

16.07

5.41

1.9

5.0

—

Other embolism and thrombosis

16.03

5.41

2.0

1.6

—

Polycystic ovarian syndrome, consortium definition

3.42

5.39

2.0

1.8

—

Acute laryngitis and tracheitis

4.73

5.37

6.1

4.6

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.15

5.37

4.8

5.4

—

Iron deficiency anaemia

3.43

5.35

4.2

3.5

—

Amblyopia ex anopsia

4.36

5.30

5.0

6.8

—

Systemic connective tissue disorders

4.34

5.29

2.7

2.9

—

All anxiety disorders

2.79

5.27

3.5

2.8

—

Diseases of the ear and mastoid process

101

2.26

5.27

3.7

2.5

—

Open bite

3.87

5.26

5.9

6.4

—

Parodontitis or operation codes

2.82

5.24

1.7

1.6

—

Other noninfective gastroenteritis and colitis

3.04

5.20

4.0

5.2

—

Diseases of the skin and subcutaneous tissue

2.36

5.16

3.4

3.7

—

Dental pulpitis 4, only avohilmo

152

0.24

5.15

1.1

3.6

—

Used for control exclusion in common control thyroid runs

119

2.13

5.15

3.9

4.3

—

Diseases of the respiratory system

3.34

5.11

3.7

2.4

—

Drug-induced polyneuropathy

13.66

5.11

3.0

6.7

—

Hypothyroidism and >3 levothyroxin purchases

7.67

5.06

2.6

4.3

—

Hypothyroidism, levothyroxine purchases

7.67

5.06

2.6

4.3

—

Tooth agenesis EXCLUDE clefts and syndromes

4.47

5.03

4.8

6.2

—

Purpura and other haemorrhagic conditions

4.45

5.03

4.7

5.6

—

Enlarged lymph nodes

10.01

5.02

4.8

2.7

—

Dental pulpitis 1, only avohilmo

149

0.25

5.00

1.1

3.5

—

Covid-19 suspected case

3.89

4.98

5.0

3.5

—

Bacterial pneumonia (organism specified)

3.09

4.97

3.0

3.6

—

Acute bronchitis

2.88

4.93

3.7

4.4

—

Tonsillectomy and adenotomy

117

2.26

4.91

5.2

4.3

—

Inguinal hernia

2.62

4.86

5.7

3.2

—

Visual disturbances and blindness

2.77

4.86

3.6

4.3

—

Herpesviral [herpes simplex] infections

9.01

4.78

5.3

2.9

—

Polyuria

9.01

4.78

1.4

1.8

—

Asthma, excluding more controls

3.33

4.75

2.6

2.2

—

Asthma

3.25

4.60

2.6

2.2

—

Bacterial pneumoniae

3.27

4.60

3.1

3.5

—

Keratitis

3.34

4.59

1.8

3.1

—

Non-follicular lymphoma, hilmo, excluding all cancers

14.02

4.57

2.6

3.6

—

Atrial fibrillation and flutter

8.16

4.57

1.2

1.5

—

Diseases of oesophagus, stomach and duodenum

108

2.19

4.56

1.6

3.6

—

Glaucoma suspect

4.76

4.53

1.6

1.4

—

STROKE

3.37

4.49

1.7

2.2

—

Asthma (only as main-diagnosis), excluding more controls

3.35

4.49

2.8

2.2

—

Psychiatric diseases

2.20

4.48

4.3

3.0

—

Umbilical hernia

4.00

4.43

5.3

2.1

—

Disorders of gallbladder, biliary tract and pancreas

2.38

4.41

3.7

2.1

—

Asthma (only as main-diagnosis)

3.29

4.40

2.8

2.2

—

Congenital malformations and deformations of the musculoskeletal system

2.92

4.39

5.7

6.5

—

Bacterial pneumonia, not elsewhere classified

3.29

4.38

2.9

3.4

—

Other disorders of bladder

11.68

4.27

1.0

1.8

—

Abnormalities of breathing

105

2.15

4.24

3.5

3.6

—

Symptoms and signs involving the circulatory and respiratory systems

107

2.06

4.23

4.3

3.6

—

Hernia of abdominal wall

3.04

4.23

5.1

2.3

—

Chronic periodontitis, including avohilmo

2.57

4.16

1.5

1.7

—

Acute pancreatitis (for exclusion)

6.93

4.16

3.8

2.7

—

Excessive, frequent and irregular menstruation

3.90

4.14

2.6

2.3

—

Parodontitis

2.56

4.13

1.5

1.7

—

Exclusions for E4_PCOS_BROAD

2.80

4.11

6.3

5.4

—

Motor disorders, excluding more controls

4.09

4.08

5.5

6.2

—

Complications of procedures, not elsewhere classified

2.55

4.06

2.3

2.8

—

Thrombocytopenia, unspecified

8.02

4.06

6.0

5.9

—

Gout, unspecified

8.01

4.06

2.3

1.3

—

Undetermined asthma, excluding more controls

8.00

4.05

3.4

2.7

—

Undetermined asthma

8.00

4.05

3.4

2.7

—

Other benign neoplasms of skin

3.52

4.04

2.1

2.6

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.68

4.03

6.4

6.7

—

In situ neoplasms

6.60

4.01

1.3

1.2

—

Codeine

2.69

3.98

1.4

—

Astigmatism

3.94

3.97

8.4

6.7

—

Autoimmune diseases

123

1.95

3.96

3.0

4.2

—

Fitting and adjustment of other devices

6.44

3.93

2.8

3.2

—

Asthma (mode)

2.98

3.91

2.2

2.3

—

Chondropathies

4.17

3.88

4.3

2.7

—

Benign neoplasms

106

2.05

3.86

2.9

3.4

—

Viral pneumonia (unknown virus, not influenza)

7.29

3.86

2.9

4.8

—

Any mental disorder

2.08

3.85

4.4

3.0

—

Pruritus

6.01

3.81

2.0

2.8

—

Phlebitis and thrombophlebitis (not including DVT)

6.00

3.81

1.2

1.3

—

Sequelae of external causes of morbidity and mortality

3.80

2.5

2.7

—

Acute lymphocytic leukaemia

8.97

3.80

5.3

6.9

—

Other coagulation defects

8.77

3.77

2.1

3.3

—

Non-follicular lymphoma

8.76

3.77

2.6

—

Neuromuscular dysfunction of bladder

12.02

3.76

2.2

2.0

—

Benign neoplasm: Skin of other and unspecified parts of face

12.01

3.76

1.0

—

Anxiety (asthma-related co-morbidities)

2.33

3.76

3.5

3.1

—

Coronary atherosclerosis

3.13

3.73

1.0

1.2

—

Continuous positive airway pressure

3.57

3.68

6.8

5.8

—

Gout, idiopatic and unspecified

6.67

3.67

2.3

1.2

—

Chronic gastritis

6.67

3.67

1.0

1.4

—

Pure hypercholesterolaemia

2.92

3.62

1.2

2.5

—

Infections with a predominantly sexual mode of transmission

3.43

3.61

1.4

1.6

—

Other anxiety disorders

2.79

3.60

2.3

2.6

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

7.97

3.58

5.3

6.6

—

Acute lymphocytic leukaemia, helper endpoint

7.97

3.58

5.3

6.6

—

Procreative management

2.29

3.55

4.8

5.1

—

Chronic pancreatitis

7.79

3.55

2.0

1.9

—

Gastroduodenal ulcer

7.76

3.55

1.7

1.4

—

Acute pancreatitis

5.30

3.50

3.8

2.5

—

Cardiomyopathy, other and unspecified

10.02

3.49

3.2

6.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

10.01

3.49

3.5

2.0

—

COPD-related respiratory insufficiency

10.01

3.49

1.0

—

Seborrhoeic keratosis

10.01

3.49

2.0

2.2

—

Noninfectious colitis NAS

3.55

3.48

1.9

4.5

—

Pain (limb, back, neck, head abdominally)

2.05

3.47

4.7

4.2

—

Retention of urine

5.44

3.47

1.1

2.4

—

Osteoporosis

5.87

3.37

2.9

3.8

—

Cardiomyopathy

5.00

3.36

2.9

4.8

—

Hypopituitarism

3.25

3.34

6.8

6.3

—

Abdominal and pelvic pain

1.97

3.32

4.7

3.9

—

Type 2 diabetes

2.34

3.29

1.3

1.5

—

Delayed milestone in childhood

2.59

3.28

6.0

7.3

—

Diseases of the musculoskeletal system and connective tissue

1.98

3.26

4.6

5.0

—

Non-allergic asthma (mode)

4.70

3.20

5.2

2.9

—

Non-allergic asthma (mode), excluding more controls

4.70

3.20

5.2

2.9

—

Hard cardiovascular diseases

2.41

3.13

2.7

2.1

—

Embedded and impacted teeth

2.51

3.12

3.9

4.1

—

In situ neoplasms

4.50

3.11

1.3

1.2

—

117

2.12

3.08

4.0

4.9

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

5.05

3.06

4.4

5.9

—

Injury of muscle and tendon at wrist and hand level

5.01

3.05

1.1

1.7

—

Specific development disorders of scholastic skills

3.05

3.03

6.3

5.9

—

Dental caries 1 and operation codes, only avohilmo

0.27

3.01

1.8

5.3

—

Parodontitis and operation codes

2.30

2.99

1.5

1.6

—

Other congenital malformations of upper alimentary tract

10.17

2.99

7.0

5.6

—

Asthma, unspecified (mode), excluding more controls

3.32

2.99

3.5

2.1

—

DVT of lower extremities and pulmonary embolism

4.27

2.98

2.1

1.2

—

Other neurological diseases

2.39

2.95

2.2

2.9

—

Malnutrition

4.75

2.92

4.5

6.5

—

Depression medications

5.75

2.92

3.0

3.9

—

Abscess of anal and rectal regions

4.71

2.91

1.3

4.4

—

Sequelae with surgical and medical care as external cause

4.71

2.91

3.1

2.3

—

Pain in limb

110

1.97

2.91

4.0

3.7

—

Ischemic heart diseases

2.43

2.88

2.3

1.7

—

Asthma, unspecified (mode)

3.23

2.88

3.5

2.1

—

Embedded teeth, including avohilmo

4.10

2.88

2.9

3.9

—

Haemolytic anaemias

6.69

2.87

7.7

4.9

—

Unspecified privation

5.39

2.87

2.7

3.8

—

Use of pramipexole

5.39

2.86

1.4

2.2

—

Misadventures to patients during surgical and medical care

6.67

2.86

2.5

1.0

—

Explicit bacterial Sepsis

6.67

2.86

4.8

4.9

—

Specific development disorders of speech and language

2.59

2.83

7.1

6.5

—

Acne

3.06

2.80

5.5

4.1

—

Mandibular retrognathia

3.05

2.79

9.1

5.6

—

Noninfective enteritis and colitis

103

2.13

2.79

3.9

4.6

—

Cerebral cysts

8.35

2.75

2.4

4.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

8.34

2.75

4.4

4.7

—

Amenorrhoea

8.34

2.75

1.4

2.8

—

Hypokalaemia

8.34

2.75

5.2

4.3

—

Disorders of synovium and tendon

2.55

2.74

2.9

2.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

5.00

2.72

2.1

2.6

—

Perforation of tympanic membrane

6.01

2.70

6.2

5.0

—

Nontraumatic intracranial haemmorrhage

6.00

2.69

2.8

2.1

—

Visual disturbances

2.25

2.60

3.9

4.3

—

Nerve, nerve root and plexus disorders

2.04

2.59

1.5

2.0

—

Coxibs

0.00

2.57

0.0

1.7

—

Hyperfunction of pituitary gland

7.16

2.55

3.0

4.6

—

Other otitis externa (chronic)

7.15

2.55

5.2

3.1

—

Other osteochondropathies

7.15

2.55

5.8

2.9

—

Other infectious diseases

7.15

2.55

2.8

3.4

—

Bronchitis, not specified as acute or chronic

7.15

2.55

1.6

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

7.15

2.55

4.4

4.7

—

Disturbance of activity and attention

2.43

2.54

6.3

5.2

—

Other and unspecified iron deficiency

2.73

2.54

5.1

3.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.50

2.52

3.2

2.8

—

Triptan medication for migraine, single purchase ok

110

0.31

2.49

2.0

3.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

110

0.31

2.49

2.0

3.0

—

Impacted cerumen

4.38

2.47

5.9

5.4

—

Orchitis and epididymitis

4.38

2.47

3.1

3.8

—

Dental caries 3 and operation codes, only avohilmo

107

0.38

2.44

4.6

5.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3.02

2.43

1.0

1.5

—

Dermatitis and eczema

150

1.70

2.42

3.3

3.6

—

Dental caries 3 and operation codes

1.84

2.42

3.9

4.5

—

Anti-inflammatory and antirheumatic products, non-steroids

0.30

2.42

1.0

4.0

—

Other diseases of intestines

146

1.67

2.38

2.8

4.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.20

2.38

2.1

1.8

—

Streptococcal septicaemia

6.26

2.37

5.4

4.8

—

Rosacea

6.26

2.37

4.2

2.5

—

Secondary uncertain malignant neoplasm

6.25

2.37

4.4

3.8

—

Atrophic disorders of skin

6.25

2.37

5.4

4.0

—

Fracture of rib(s), sternum and thoracic spine

3.64

2.36

1.1

2.1

—

Asthma, hospital admission 2, infections

130

1.89

2.33

4.0

4.5

—

Asthma-related infections

130

1.89

2.33

4.0

4.5

—

Hypothyroidism, strict autoimmune

2.25

2.28

1.9

3.3

—

Polyarthropathies

1.95

2.28

2.3

3.4

—

Pain associated with micturition

4.62

2.27

4.2

5.8

—

Persons encountering health services in other circumstances

2.45

2.27

4.1

4.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

3.66

2.24

1.5

1.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.65

2.22

4.8

5.6

—

Special screening examination for infectious and parasitic diseases

4.03

2.22

1.6

1.2

—

Cardiac murmurs and other cardiac sounds

2.53

2.21

6.8

6.1

—

Juvenile osteochondrosis

5.57

2.21

4.6

4.2

—

Gout, strict definition

5.56

2.21

1.4

1.3

—

Diseases of the digestive system

2.19

2.5

3.9

—

Ischaemic heart disease, wide definition

2.28

2.17

1.0

1.3

—

Mental retardation, excluding more controls

3.29

2.14

5.8

6.9

—

Pregnancy hypertension

3.00

2.12

1.0

1.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.45

2.10

3.9

4.1

—

Contraceptive management

2.34

2.08

2.3

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.88

2.07

2.0

2.3

—

Budesonide

5.00

2.07

1.0

1.6

—

Early onset COPD, excluding more controls

5.00

2.07

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.50

2.05

1.3

2.0

—

Nail disorders

4.00

2.04

3.0

4.5

—

Trigger finger

4.00

2.04

1.0

2.0

—

Other gastritis (incl. Duodenitis)

4.00

2.04

1.0

2.1

—

Congenital malformations of the circulatory system

1.98

2.03

5.0

6.1

—

Pulmonary embolism

4.00

2.03

2.7

1.3

—

Pulmonary heart disease

4.00

2.03

2.7

1.3

—

Injuries to the thorax

2.40

2.02

1.4

2.3

—

Disorders of puberty, all

3.10

2.02

4.3

6.2

—

Asthma-related pneumonia

2.10

2.01

4.1

5.1

—

Asthma, hospital admissions 3, pneumonia

2.10

2.01

4.1

5.1

—

Asthma-related pneumonia or sepsis

2.10

2.01

4.1

5.1

—

Corneal ulcer

3.08

2.01

1.3

3.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

104

1.92

1.99

3.4

4.7

—

Urticaria

2.08

1.96

6.9

4.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.09

1.95

2.1

3.1

—

Congenital deformities of feet

4.56

1.94

4.4

5.6

—

Seborrhoeic dermatitis

4.55

1.94

5.0

4.6

—

Other complications of surgical and medical care, not elsewhere classified

4.55

1.94

2.8

2.1

—

Dermatophytosis

4.55

1.94

3.2

2.8

—

Pre-eclampsia

4.55

1.94

1.0

1.3

—

Pre-eclampsia or eclampsia

4.55

1.94

1.0

1.3

—

Conductive hearing loss, unspecified

3.75

1.93

5.3

4.3

—

Other and unspecified local infections of skin and subcutaneous tissue

3.75

1.93

5.2

4.7

—

Parodontitis, operation under 40 years and operation codes

3.75

1.93

3.8

3.1

—

Parodontitis, under 40 years, or operation codes

3.75

1.93

3.8

3.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

3.45

1.92

1.0

1.4

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

3.44

1.92

1.0

1.4

—

Other disorders of eyelid

2.72

1.91

1.3

2.6

—

Sequelae of cerebrovascular disease

3.76

1.90

1.0

1.2

—

Urticaria and erythema

2.00

1.89

6.5

4.5

—

Congenital malformations of heart and great arteries

1.96

1.89

4.6

6.4

—

Other disorders of glucose regulation and pancreatic internal secretion

3.19

1.88

2.3

6.0

—

Conjunctivitis (acute, non atopic)

1.95

1.87

4.8

5.0

—

Hyperplasia of prostate

2.85

1.87

1.0

—

Specific developmental disorder of motor function

2.42

1.86

5.5

7.0

—

Phobic anxiety disorders

2.86

1.86

4.1

3.6

—

Heart failure and coronary heart disease

3.73

1.84

3.8

2.0

—

Convergent concomitant strabismus

3.54

1.83

3.8

5.9

—

Other local infections of skin and subcutaneous tissue

3.53

1.83

5.2

4.5

—

Soft tissue disorders related to use, overuse and pressure

3.53

1.83

2.0

1.2

—

Mood disorders, excluding more controls

1.88

1.80

2.1

1.8

—

Haemorrhage from respiratory passages

2.37

1.80

2.5

4.0

—

Other disorders of lacrimal gland

2.57

1.80

3.1

2.7

—

Other systemic involvement of connective tissue

3.04

1.79

1.9

2.2

—

Diaphragmatic hernia

3.04

1.79

1.4

1.7

—

Autoimmune diseases related-to ILD

127

1.73

1.79

2.9

3.0

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.88

1.78

1.5

1.4

—

Diabetes mellitus

112

1.65

1.76

1.6

4.0

—

Mouth breathing

109

1.83

1.76

5.2

4.7

—

Mild mental retardation

3.35

1.75

5.5

5.2

—

Emotional disorders starting during childhood or adolescence

2.33

1.74

4.8

6.0

—

Other skin changes

3.34

1.74

2.2

3.1

—

Functional dyspepsia

2.92

1.72

1.0

2.5

—

Chronic diseases of tonsils and adenoids

135

1.59

1.71

4.8

3.9

—

Visual impairment including blindness (binocular or monocular)

3.85

1.71

2.4

5.8

—

Codeine or tramadol medication

1.77

1.71

1.4

—

Lower back pain or/and sciatica

115

0.42

1.71

1.4

2.0

—

Inflammatory diseases of female pelvic organs

2.26

1.71

1.7

1.8

—

Motor disorders

2.31

1.70

5.5

7.2

—

Parasetamol

1.78

1.69

2.3

2.9

—

Basal cell carcinoma

2.94

1.68

1.0

1.3

—

Persons encountering health services in circumstances related to reproduction

125

1.63

1.66

4.3

4.5

—

Dental caries 3

1.68

1.66

4.2

4.8

—

Disorders of optic nerve and visual pathways

3.16

1.66

2.8

4.9

—

Other systemic involvement of connective tissue (FG)

3.14

1.65

1.8

2.1

—

Other disorders of ear

113

1.65

1.64

4.6

3.5

—

Oral corticosteroids

1.77

1.61

2.2

2.1

—

Other and unspecified injuries of lower leg

3.58

1.61

3.6

5.1

—

Ventral hernia

3.57

1.61

5.6

1.4

—

Disorders of eyelid, lacrimal system and orbit

1.74

1.60

2.8

3.4

—

Other disorders of eye and adnexa

2.50

1.59

4.5

4.2

—

Scissor bite

2.33

1.59

7.7

6.1

—

Basal cell carcinoma, including avohilmo

2.76

1.57

1.0

1.3

—

Non-invasive ventilation

2.97

1.55

5.8

4.4

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.67

1.54

4.0

3.0

—

Unspecified acute lower respiratory infection

2.43

1.53

4.1

3.4

—

COPD related to multimorbidity

2.97

1.53

1.0

1.2

—

Acne vulgaris

2.60

1.51

3.6

3.9

—

Anterior Iridocyclitis

2.59

1.51

1.6

2.3

—

Diagnoses used for exclusion with ILD

2.86

1.50

4.0

1.4

—

Pulmonary heart disease, diseases of pulmonary circulation

2.86

1.50

2.7

2.1

—

Slow fetal growth and fetal malnutrition

2.88

1.50

3.7

6.5

—

Diabetes, varying definitions

113

1.59

1.50

1.7

3.9

—

Respiratory distress of newborn

2.08

1.47

5.4

6.9

—

Coronary angioplasty

2.88

1.47

5.2

2.4

—

Other soft tissue disorders, not elsewhere classified

118

1.57

1.45

4.0

3.8

—

Cardiovascular disorders originating in the perinatal period

3.19

1.44

5.6

—

Other disorders of optic [2nd] nerve and visual pathways

3.13

1.44

3.0

5.5

—

Cerebral palsy and other paralytic syndromes

2.73

1.43

3.5

4.3

—

Fracture of femur

2.74

1.42

2.3

3.9

—

Pregnancy, childbirth and the puerperium

0.00

1.42

0.0

2.3

—

Stroke, including SAH

2.07

1.41

1.9

1.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.39

0.0

1.1

—

Hyperkinetic disorders

1.85

1.39

6.3

5.9

—

Open wound of lower leg

2.42

1.39

1.6

4.4

—

Diabetes, insulin treatment (Kela reimbursement)

109

1.57

1.37

1.5

3.8

—

Malignant neoplasm of breast

0.00

1.37

0.0

1.3

—

Congenital malformations of pulmonary and tricuspid valves

2.97

1.36

6.4

7.1

—

Syncope and collapse

2.39

1.35

1.0

1.9

—

Major coronary heart disease event

1.97

1.34

2.9

1.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.87

1.33

3.0

3.9

—

Burns and corrosions of external body surface, specified by site

0.00

1.33

0.0

5.3

—

Degeneration of macula and posterior pole

2.60

1.33

1.0

2.1

—

Contact with and exposure to communicable diseases

1.75

1.33

4.6

4.9

—

Cerebrovascular diseases

1.85

1.33

2.3

1.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

105

1.57

1.32

1.6

4.0

—

Conductive and sensorineural hearing loss

1.69

1.32

4.9

3.0

—

Coronary revascularization (ANGIO or CABG)

2.43

1.31

4.1

2.0

—

Parodontitis or/and operation codes

1.75

1.30

2.0

1.7

—

Other specified congenital malformation syndromes affecting multiple systems

2.51

1.30

3.5

7.5

—

Acute and subacute iridocyclitis

2.50

1.30

1.7

2.1

—

Fissure and fistula of anal and rectal regions

2.50

1.30

3.0

1.5

—

Abnormal findings on diagnostic imaging of lung

2.36

1.29

1.5

1.8

—

Disorders of puberty

2.79

1.28

4.2

6.3

—

Congenital deformities of hip

2.79

1.28

5.8

5.9

—

Allergic urticaria

2.78

1.28

7.8

5.9

—

Dysphagia

2.78

1.28

3.8

2.7

—

Other disorders originating in the perinatal period

2.31

1.27

6.9

6.5

—

Abrasion of teeth

2.83

1.26

1.2

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

2.29

1.25

1.1

1.3

—

Injury, poisoning and certain other consequences of external causes

1.65

1.25

4.4

4.9

—

Finngen Rheumatological endpoints

104

1.53

1.25

2.6

3.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.86

1.23

6.2

4.6

—

Other diseases of pleura

2.22

1.23

2.0

3.5

—

Other diseases of the digestive system

2.00

1.23

3.7

3.6

—

GI-bleeding

2.00

1.23

3.7

3.6

—

Disorders of speech understanding and production

2.05

1.22

7.0

—

Fracture of skull and facial bones

2.16

1.21

4.5

3.2

—

Exposure to unspecified factor

170

1.46

1.21

3.1

4.0

—

Malignant neoplasm of digestive organs

2.59

1.19

4.0

1.6

—

Stroke, excluding SAH

2.06

1.19

2.1

1.7

—

Impetigo

2.31

1.18

5.3

6.8

—

Emergency coronary revascularization (for ACS)

2.13

1.17

4.1

1.9

—

Myocardial infarction

2.13

1.17

1.1

1.5

—

Malignant neoplasm of breast, HER2-negative

0.00

1.17

0.0

1.3

—

Mixed specific developmental disorders

1.94

1.16

5.9

6.8

—

Non-selective monoamine reuptake inhibitors

0.00

1.16

0.0

1.3

—

Ischaemic Stroke, excluding all haemorrhages

2.09

1.15

1.6

1.8

—

Hypoglycaemia, other or unspecified

2.50

1.15

1.6

6.3

—

Early onset COPD

2.50

1.15

1.0

2.3

—

Other degenerative diseases of the nervous system

2.53

1.13

1.4

1.0

—

Conotruncal defects

2.35

1.12

6.0

6.7

—

Allergic asthma (mode)

2.45

1.12

4.0

2.9

—

Allergic asthma (mode), excluding more controls

2.45

1.12

4.0

2.9

—

Colonic or urogenital fistula

2.33

1.12

3.4

1.6

—

Disturbances of skin sensation

2.33

1.12

1.9

—

Superficial injury of ankle and foot

2.26

1.10

4.7

5.3

—

Iridocyclitis

2.26

1.10

1.6

2.8

—

Artrosis, including avohilmo

0.46

1.10

1.8

1.3

—

Right ventricular outflow tract obstruction

2.40

1.09

6.4

6.8

—

Menorrhagia

2.28

1.09

2.1

1.5

—

Congenital malformations of the respiratory system

2.39

1.09

4.4

5.7

—

Benign paroxysmal vertigo

2.38

1.09

1.2

2.2

—

Hydrocele

2.38

1.09

5.4

4.7

—

Sleep apnoea, including avohilmo

0.52

1.06

2.8

2.0

—

Diabetes medication

116

1.47

1.06

1.6

3.8

—

Fracture of shoulder and upper arm

1.76

1.06

2.7

4.4

—

Disorders of conjunctiva

155

1.46

1.05

4.5

4.0

—

Gastro-oesophageal reflux disease

1.65

1.04

1.9

3.6

—

Female genital prolapse

2.41

1.03

2.2

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.06

1.02

2.1

5.7

—

Disorders of lacrimal system

1.89

1.01

2.9

3.1

—

Vasomotor and allergic rhinitis

104

0.47

1.01

2.2

4.7

—

Diseases of male genital organs

1.49

0.98

4.9

4.7

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.80

0.98

5.5

3.7

—

Heterophoria

2.18

0.98

5.2

6.3

—

Abnormalities of gait and mobility

2.18

0.98

3.6

5.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.97

0.0

2.2

—

Conjunctivitis

150

1.45

0.97

4.8

4.1

—

Non-allergic asthma

1.95

0.97

5.4

6.3

—

Fracture of forearm

1.63

0.96

2.7

4.0

—

Adverse effects, not elsewhere classified

1.80

0.96

5.0

—

Fracture of foot, except ankle

1.80

0.96

5.0

3.5

—

Artificial joint operation, meniscal resection

0.49

0.96

1.5

—

Paracetamol of NSAID medication

0.46

0.94

3.2

5.1

—

Acute alcohol intoxication

1.89

0.94

2.3

2.4

—

Soft tissue disorders

128

1.38

0.93

4.1

3.9

—

Benign neoplasm: Colon

2.19

0.92

1.2

1.3

—

Impacted teeth

1.83

0.92

5.4

4.1

—

Other dorsopathies, not elsewhere classified

111

0.62

0.91

2.8

2.7

—

Benign neoplasm: Colon

2.10

0.90

1.2

—

Exclusion endpoint for clefts

2.08

0.89

3.5

7.0

—

Injuries to the ankle and foot

145

1.44

0.89

4.9

3.6

—

Intestinal stricture

2.07

0.89

1.0

3.2

—

Benign neoplasm of colon, rectum, anus and anal canal

1.90

0.88

1.1

1.2

—

Ovarian cyst

2.04

0.86

1.8

1.5

—

External causes of morbidity and mortality

1.45

0.86

4.3

4.4

—

1.61

0.85

1.9

2.0

—

Mental and behavioural disorders due to alcohol

1.67

0.85

1.8

2.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.67

0.85

4.1

4.6

—

COPD, hospital admissions

1.95

0.84

1.0

2.0

—

COPD, early/later onset

1.95

0.84

1.0

2.0

—

Other chronic obstructive pulmonary disease

1.92

0.83

1.0

2.2

—

Single delivery by forceps and vacuum extractor

0.00

0.82

0.0

1.5

—

Acute alcohol intoxication, ICD10

1.88

0.81

2.3

2.6

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.00

0.80

0.0

1.3

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.00

0.80

0.0

1.3

—

Substance abuse, excluding more controls

1.69

0.80

1.5

1.6

—

Other/unspecified dorsalgia

1.69

0.80

3.5

2.5

—

Premature rupture of membranes

0.00

0.80

0.0

1.4

—

Transient ischemic attack

1.84

0.79

1.0

1.4

—

COPD

1.83

0.79

1.0

2.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.52

0.78

3.2

3.6

—

Superficial injury of forearm

0.00

0.77

0.0

5.7

—

Other and unspecified disorders of psychological development

0.00

0.77

0.0

7.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.19

0.76

1.0

1.3

—

Bacterial sepsis of newborn

2.11

0.75

8.4

6.8

—

1.57

0.74

1.7

2.1

—

Aortic valve malfunction, age under 60 years

2.08

0.74

2.6

5.3

—

Personality disorders, excluding more controls

2.08

0.74

2.0

1.3

—

All dysplastic lesions of the cervix uteri, vagina or vulva

2.07

0.74

1.4

1.2

—

Neurological diseases

130

1.32

0.73

3.5

4.6

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2.05

0.73

4.0

1.8

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.84

0.73

3.1

6.7

—

Depression or dysthymia

1.57

0.73

2.5

2.0

—

5-aminosalicylic acid

2.00

0.72

5.0

3.0

—

Urolithiasis

2.00

0.72

6.8

2.5

—

Depression

120

1.38

0.72

2.0

2.8

—

Other arthrosis

1.61

0.72

1.7

1.4

—

Other congenital malformations

1.61

0.72

4.4

6.5

—

Undescended testicle

1.93

0.70

7.8

6.9

—

Weight loss

1.92

0.70

7.4

4.9

—

Pre-eclampsia or poor fetal growth

1.92

0.70

1.0

1.4

—

Biguanides

0.59

0.70

1.4

1.3

—

Mood [affective] disorders

121

1.36

0.70

2.0

2.7

—

Type of accident

1.55

0.69

6.1

3.5

—

Injuries to the elbow and forearm

129

1.40

0.69

3.5

4.0

—

Mood disorders

121

1.36

0.69

2.0

2.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.47

0.68

1.9

2.5

—

Myopia

1.85

0.68

6.0

4.6

—

Other disorders of veins

1.85

0.68

1.0

1.3

—

Other and unspecified effects of external causes

1.59

0.68

4.9

4.5

—

Redundant prepuce, phimosis and paraphimosis

1.62

0.66

6.4

4.4

—

Injuries to the wrist and hand

155

1.31

0.64

1.7

3.9

—

Pain in throat and chest

1.39

0.63

3.1

2.9

—

Non-rheumatic valve diseases

1.57

0.62

3.7

4.1

—

Cholelithiasis, broad definition with cholecystitis

1.51

0.62

2.5

1.6

—

Appendectomy

1.49

0.62

2.5

2.1

—

Appendicitis, broad definition

1.44

0.61

1.9

2.0

—

Irritable bowel syndrome

1.67

0.61

1.0

2.9

—

Diseases of appendix

1.44

0.61

1.9

2.0

—

Constipation

143

0.70

0.60

3.9

4.3

—

Prolonged pregnancy

0.00

0.60

0.0

1.7

—

Hypothyroidism, other/unspecified

1.40

0.60

2.1

2.9

—

Autism spe

0.00

0.60

0.0

5.5

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.60

0.0

1.5

—

Allergic contact dermatitis

0.00

0.60

0.0

3.4

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.60

0.0

1.6

—

Other and unspecified urticaria

1.57

0.60

6.3

4.7

—

Mental retardation

1.54

0.59

5.8

7.2

—

Mental retardation, wide definition

1.54

0.59

5.8

7.2

—

Other disorders of patella

0.00

0.59

0.0

1.5

—

Eating disorder

0.00

0.59

0.0

3.9

—

Congenital malformations of genital organs

1.53

0.59

6.5

—

Valvular heart disease excluding rheumatic fever

1.51

0.59

4.7

4.5

—

Sensorineural hearing loss

1.44

0.59

4.6

2.8

—

Atopic dermatitis, strict definition with reimbursement

1.44

0.58

4.8

5.0

—

Myocardial infarction, strict

1.75

0.58

1.2

1.4

—

Cardiodefibrillation

0.00

0.58

0.0

2.1

—

Gonarthrosis,primary

0.55

0.58

1.0

1.2

—

Congenital malformations of eye, ear, face and neck

1.72

0.57

4.2

6.6

—

Diverticular disease of intestine

1.58

0.57

1.3

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.38

0.57

2.1

2.9

—

Cholelithiasis

1.50

0.57

2.4

1.6

—

Dorsalgia

107

0.71

0.56

2.6

—

Major coronary heart disease event excluding revascularizations

1.55

0.56

1.1

1.4

—

Disorders of breast

1.64

0.56

1.3

1.8

—

Infections specific to the perinatal period

1.59

0.54

8.3

6.8

—

Leisure time condition

1.58

0.54

5.5

3.6

—

Transport accidents

1.44

0.54

3.4

3.5

—

Dorsopathies

129

0.75

0.54

2.9

3.2

—

Fracture of lower leg, including ankle

1.46

0.53

3.5

3.4

—

Sleep apnoea

0.66

0.53

2.6

2.1

—

Allergic colitis

1.54

0.53

8.7

6.2

—

Type 1 diabetes, definitions combined

1.45

0.53

2.3

6.1

—

Type 1 diabetes, strict (exclude DM2)

1.43

0.52

2.3

6.0

—

Open wound of wrist and hand

1.45

0.52

1.4

3.2

—

Other chronic obstructive pulmonary disease, including avohilmo

1.51

0.52

1.0

1.9

—

Abnormalities of heart beat

1.49

0.51

3.2

2.9

—

Dental caries 1, only avohilmo

110

0.74

0.49

2.6

4.7

—

Dental pulpitis 3

0.63

0.49

4.0

6.0

—

Sleep disorders (combined)

110

0.71

0.48

2.2

2.8

—

Diseases of inner ear

1.52

0.48

1.3

1.7

—

Dental caries 2, only avohilmo

135

1.29

0.48

2.5

4.1

—

Abnormal findings on examination of blood, without diagnosis

1.45

0.48

3.2

3.6

—

Gonarthrosis [arthrosis of knee](FG)

0.60

0.47

1.0

1.2

—

Benzodiazepine use

110

0.71

0.46

2.1

—

Asthma, hospital admissions , main diagnosis only

163

1.26

0.45

3.6

3.9

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.39

0.44

1.7

1.5

—

Mental and behavioural disorders due to psychoactive substance use

1.40

0.44

1.8

2.1

—

Injuries to the knee and lower leg

140

1.23

0.44

2.7

3.4

—

Postmenopausal atrophic vaginitis

0.00

0.43

0.0

1.3

—

Postpartum care and examination

0.00

0.42

0.0

1.4

—

Postmenopausal bleeding

0.00

0.42

0.0

1.3

—

Cardiac arrhythmias

1.32

0.42

2.1

4.3

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.2

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.38

0.41

6.0

7.0

—

Liveborn infants according to place of birth

0.00

0.41

0.0

5.9

—

Impacted maxillary canine

0.00

0.41

0.0

5.1

—

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

7.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.52

0.41

5.0

2.8

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.41

0.0

3.4

—

Other diseases of anus and rectum

1.51

0.41

3.2

3.6

—

Malignant neoplasm of skin

1.51

0.41

1.0

1.2

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.35

0.41

6.0

6.9

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.40

0.0

6.7

—

Dental caries 3, only avohilmo

123

0.79

0.40

3.2

4.5

—

Personality disorders

1.47

0.40

2.0

1.6

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.33

0.40

1.1

1.6

—

Disorders of vestibular function (Vertigo)

1.46

0.40

1.2

1.8

—

Combinations of oral blood glucose lowering drugs

0.00

0.40

0.0

1.3

—

Malignant neoplasm of breast, HER-positive

0.00

0.40

0.0

1.3

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.39

0.0

6.6

—

Dyspnoea

115

1.27

0.38

1.7

3.8

—

Other disorders of penis

1.39

0.38

11.6

5.4

—

Spondylopathies

0.68

0.38

1.5

1.6

—

Pain in joint

1.34

0.38

2.5

3.5

—

Acute appendicitis

1.33

0.38

1.8

2.0

—

Use of hypnotics and sedatives

1.25

0.38

1.7

2.7

—

Other joint disorders

115

0.79

0.38

2.8

3.7

—

Dental pulpitis 4

135

0.81

0.37

2.1

4.0

—

Diseases of pulp and periapical tissues, including avohilmo

135

0.81

0.37

2.1

4.0

—

Dental pulpitis 1

135

0.81

0.37

2.1

4.0

—

Allergic conjunctivitis

113

0.70

0.37

6.1

3.5

—

Meniscus derangement

1.28

0.36

1.9

1.1

—

Shoulder lesions

1.37

0.36

1.1

1.2

—

Disorders of the thyroid gland

1.25

0.36

2.0

2.7

—

Obesity, other/unspecified

1.43

0.35

1.8

2.5

—

Fall on same level involving ice and snow

0.63

0.35

3.0

2.9

—

Angina pectoris

1.40

0.35

1.2

—

Other arthritis (FG)

1.40

0.35

3.3

3.6

—

Other functional intestinal disorders

103

1.29

0.34

4.8

5.3

—

Substance abuse

1.33

0.32

1.5

2.1

—

Episodal and paroxysmal disorders

158

0.84

0.32

3.4

4.1

—

Congenital malformations of cardiac septa

1.34

0.31

3.4

7.1

—

Carpal tunnel syndrome

1.32

0.30

1.3

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

0.71

0.30

2.6

2.4

—

Deforming dorsopathies

1.32

0.30

2.3

3.9

—

Alcohol use disorder, Swedish definition

1.33

0.29

1.5

1.8

—

Intracranial injury

125

0.77

0.28

4.3

4.5

—

Rotator cuff syndrome

1.29

0.28

1.1

1.2

—

Injuries to the hip and thigh

1.28

0.28

2.3

3.9

—

Focal epilepsy

1.25

0.27

4.4

4.9

—

Cholecystectomy

1.24

0.27

2.3

1.4

—

Gonarthrosis

0.65

0.26

1.0

1.1

—

Childhood allergy (age < 16)

1.24

0.26

4.4

5.8

—

Obesity due to excess calories

0.70

0.26

1.8

3.9

—

Dental operations, only avohilmo

1.22

0.25

3.6

4.1

—

Haemorrhagic and haematological disorders of fetus and newborn

1.20

0.25

5.7

6.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.71

0.24

4.0

2.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.70

0.23

5.7

3.8

—

Type 2 diabetes, definitions combined

0.76

0.23

1.6

1.3

—

Type 2 diabetes, strict (exclude DM1)

0.75

0.23

1.6

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

0.74

0.23

1.6

1.3

—

Other specified/unspecified arthritis

1.28

0.23

3.2

3.7

—

Diseases of liver

1.28

0.23

2.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.27

0.22

1.8

1.2

—

Atrial septal defect

1.27

0.22

3.2

6.8

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

1.0

—

AV-block

0.00

0.21

0.0

4.5

—

Congenital malformations of larynx

0.00

0.21

0.0

4.9

—

Other congenital malformations of skull and face bones

0.00

0.21

0.0

5.5

—

Complex cardiac defects

0.00

0.21

0.0

6.8

—

Disorders of adult personality and behaviour

1.19

0.21

2.4

1.9

—

Obesity related asthma

1.19

0.21

2.6

3.0

—

Disorder of the sleep-wake schedule

0.00

0.21

0.0

5.9

—

Unspecific neurodegenerative disorder

0.00

0.21

0.0

1.1

—

Autism spe, excluding more controls

0.00

0.21

0.0

6.0

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

5.4

—

Burn and corrosion of wrist and hand

0.00

0.21

0.0

4.6

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.4

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

2.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

2.2

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

4.4

—

Psoriatic arthropathies

0.00

0.21

0.0

1.3

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

1.7

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.3

—

Acute and transient psychotic disorders

0.00

0.21

0.0

1.3

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.3

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Familial hypercholesterolemia

0.00

0.21

0.0

3.9

—

Radiculopathy

0.00

0.21

0.0

1.4

—

Lichen planus, including avohilmo

0.00

0.21

0.0

1.4

—

Other external causes of accidental injury

111

0.86

0.21

4.2

3.9

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.21

0.0

5.8

—

Major anomalies of jaw size

0.00

0.21

0.0

5.2

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.21

0.0

6.2

—

Foreign body in alimentary tract

0.00

0.21

0.0

5.8

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

3.8

—

Injury of unspecified body region

0.00

0.21

0.0

4.3

—

Assault by bodily force

0.00

0.21

0.0

2.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.21

0.0

1.5

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.2

—

Other disorders of amniotic fluid and membranes

0.00

0.21

0.0

1.3

—

Other abnormal uterine and vaginal bleeding

0.00

0.21

0.0

1.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

3.2

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

3.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

3.2

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.3

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.20

0.0

6.6

—

Other eating disorders

0.00

0.20

0.0

4.8

—

FESS (DNB20)

0.00

0.20

0.0

2.4

—

Ethmoidectomy

0.00

0.20

0.0

2.4

—

Acute appendicitis, no complications

1.25

0.20

2.0

—

Internal derangement of knee

1.22

0.20

2.0

2.1

—

Glucagon-like peptide-1 (GLP-1) analogues

1.20

0.20

1.3

1.1

—

Congenital malformations of great arteries

1.16

0.19

3.0

7.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.15

0.19

1.3

3.9

—

Intracranial trauma

107

0.84

0.18

3.8

4.7

—

Atopic dermatitis

117

1.17

0.18

4.5

4.3

—

Other arrhythmias

1.23

0.18

1.6

3.2

—

Effects of foreign body entering through natural orifice

1.19

0.18

3.0

4.7

—

Asthma/COPD (KELA code 203)

160

0.88

0.17

4.2

3.8

—

Atopic dermatitis, strict definition

117

1.17

0.17

4.8

4.9

—

Dermatitis due to ingested food

0.76

0.17

5.8

6.6

—

Septal defects

1.14

0.15

3.7

6.8

—

Selective serotonin reuptake inhibitors

112

0.89

0.13

1.9

2.7

—

Asthma (diagnoses ohter than nonallergic)

164

1.09

0.10

4.1

4.0

—

Dental caries 2 and operation codes, only avohilmo

142

0.92

0.10

2.6

4.2

—

IBD patients in KELA-register

1.09

0.09

5.0

3.4

—

Ulcerative colitis

1.09

0.09

5.2

3.5

—

Alcohol use disorder, ICD-based

1.05

0.08

1.2

1.6

—

Pregnancy with abortive outcome

0.77

0.08

1.0

1.7

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.81

0.08

1.0

3.7

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.03

0.08

7.3

6.7

—

Falls/tendency to fall

154

0.94

0.07

4.7

3.8

—

Concussion

106

0.90

0.07

3.9

4.5

—

Injuries to the head

172

1.06

0.07

3.8

—

Arthrosis

0.88

0.07

1.6

1.3

—

Dizziness and giddiness

0.84

0.06

1.5

2.4

—

Striking against or struck by other objects

0.86

0.06

2.0

4.5

—

Exposure to other specified factors

158

1.07

0.05

2.3

3.7

—

Epilepsy

1.11

0.05

4.2

5.1

—

Accidents

111

0.95

0.04

4.0

3.9

—

Asthma, including avohilmo

169

0.96

0.03

3.4

3.8

—

Arthropathies

127

1.04

0.03

3.0

4.0

—

Exclusions for E4_PCOS_CONSORTIUM

107

1.05

0.03

5.0

4.1

—

Injuries to the shoulder and upper arm

132

0.95

0.02

2.5

3.2

—

Open wound of head

121

1.06

0.02

4.6

4.5

—

Unspecified fall

116

0.94

0.01

4.5

5.0

—

Other diseases of upper respiratory tract

145

0.97

0.01

4.3

3.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

116

0.97

0.00

2.0

2.7

—

Other antidepressants

1.02

0.00

1.8

1.9

—

Other nutritional deficiencies

102

0.96

0.00

1.8

3.4

—

Other (not insulin) diabetes medications

0.97

0.00

1.6

1.4

—

Fall on same level

166

1.01

0.00

4.2

3.7

—

Other specific joint derangements/joint disorders

103

0.98

0.00

2.3

3.4

—

Migraine

1.04

0.00

3.0

3.9

—

Chronic lower respiratory diseases

165

1.02

0.00

3.4

3.8

—

Operations 1 for CAVS

0.00

0.0

8.0

—

Failed induction of labour

0.00

0.0

1.2

—

Nummular dermatitis

0.00

0.0

1.7

—

Injury of intra-abdominal organs

0.00

0.0

4.7

—

Other fall from one level to another

0.93

0.00

3.0

5.6

—

D07AA Corticosteroids, weak (group I)

1.01

0.00

3.1

6.0

—

Non-small cell lung cancer

0.00

0.0

1.0

—

Pedal cyclist injured in transport accident

0.93

0.00

5.4

4.0

—

Maxillary prognathism

0.00

0.0

4.7

—

Unspecified jaundice

0.00

0.0

5.0

—

Multiple delivery

0.00

0.0

1.3

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.6

—

Alzheimer disease, including avohilmo

0.00

0.0

1.1

—

Other congenital malformations of peripheral vascular system

0.00

0.0

4.3

—

Lactose intolerance

0.00

0.0

4.8

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.0

4.5

—

Fibrosis and cirrhosis of liver

0.00

0.0

2.0

—

Malignant neoplasm of bronchus and lung

0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

6.2

—

Ulcerative proctitis

0.00

0.0

3.4

—

Disorder of visual pathways, unspecified

0.00

0.0

5.8

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Open wound of hip and thigh

0.00

0.0

4.2

—

Digestive system disorders of fetus and newborn

0.00

0.0

6.3

—

Psoriatic arthropathies, ICD10

0.00

0.0

1.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

0.0

6.2

—

malignant neoplasm of female genital organs

0.00

0.0

2.4

—

Other and unspecified visual disturbances

0.00

0.0

3.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.0

1.6

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.0

5.0

—

Metatarsalgia

0.00

0.0

2.9

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.6

—

Maltreatment syndromes

0.00

0.0

3.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.2

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.0

3.3

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Lichen planus

0.00

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

0.0

2.6

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

3.0

—

Transient global amnesia

0.00

0.0

1.0

—

Reimbursement for rheumatic diseases

0.95

0.00

4.4

3.7

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

1.5

—

Focal epilepsy, strict definition

1.02

0.00

4.3

4.9

—

Lactose intolerance, other/unspecified

0.00

0.0

4.8

—

Sudden idiopathic hearing loss

0.00

0.0

1.5

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

5.1

—

Parkinson's disease

0.00

0.0

1.0

—

Other psoriatic arthropathies

0.00

0.0

1.5

—

Other perinatal haematological disorders

0.00

0.0

5.5

—

Microcephaly

0.00

0.0

4.6

—

Congenital malformations of lung

0.00

0.0

4.8

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.0

3.6

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.0

1.0

—

Other osteochondrodysplasias

0.00

0.0

5.6

—

Malignant melanoma of skin

0.00

0.0

1.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

4.8

—

Medical abortion

0.85

0.00

1.4

1.7

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.1

—

Malignant neoplasm of head and neck

0.00

0.0

1.6

—

Abnormal spermatozoa

0.00

0.0

1.0

—

Chronic laryngitis and laryngotracheitis

0.00

0.0

1.4

—

Superficial injury of lower leg

0.86

0.00

2.0

3.7

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

0.0

1.6

—

Colorectal adenocarcinoma

0.00

0.0

1.4

—

Toxic effect of contact with venomous animals

0.00

0.0

5.4

—

Burns classified according to extent of body surface involved

0.00

0.0

3.7

—

Benign leiomyoma with endometriosis

0.00

0.0

1.3

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.0

4.6

—

Other and unspecified injuries of head

0.00

0.0

5.0

—

Open wound of abdomen, lower back and pelvis

0.00

0.0

4.8

—

Multiple gestation

0.00

0.0

1.3

—

Benign neoplasm of eye and adnexa

0.00

0.0

2.2

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

3.2

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Foreign body or object entering through skin

0.00

0.0

3.5

—

Other puerperal infections

0.00

0.0

1.1

—

Lichen simplex chronicus and prurigo

0.00

0.0

3.0

—

Malignant neoplasm of endocrine gland

0.00

0.0

4.4

—

Struck by thrown, projected or falling objec

0.00

0.0

6.1

—

Alcoholic liver disease

0.00

0.0

1.5

—

Colon adenocarcinoma

0.00

0.0

1.0

—

Neonatal jaundice from other and unspecified causes

0.95

0.00

4.7

6.8

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

1.2

—

Unspecified event, undetermined intent

0.00

0.0

5.2

—

Other headache syndromes

0.89

0.00

1.0

2.4

—

Amiodarone users

0.00

0.0

1.5

—

Use of anticholinesterases

0.00

0.0

1.1

—

Use of memantine

0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

2.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.6

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

6.2

—

Alzheimer disease

0.00

0.0

1.0

—

Benign neoplasm of eye and adnexa

0.00

0.0

2.8

—

Twin gestation

0.00

0.0

1.3

—

Use of donepezil

0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

6.0

—

Use of other anti-dementia drugs

0.00

0.0

1.0

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

0.0

1.0

—

Other obstetric trauma

0.00

0.0

1.1

—

Use of rivastigmine

0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Down's syndrome

0.00

0.0

4.9

—

Phakomatoses, not elsewhere classified

0.00

0.0

6.3

—

Muscular dystrophy

0.00

0.0

7.0

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

5.4

—

Type1 diabetes, definitions combined, early onset

1.01

0.00

3.0

6.3

—

Wet age-related macular degeneration

0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

0.0

1.3

—

Varicose veins of other sites

0.00

0.0

3.3

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

2.8

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

0.0

3.9

—

Recurrent or chronic depression

0.98

0.00

1.4

1.6

—

Inflammatory bowel disease, strict (require KELA)

0.98

0.00

5.0

3.3

—

Inflammatory bowel disease

1.02

0.00

4.5

3.5

—

Benign leiomyoma with endometriosis

0.00

0.0

1.4

—

Adenomyosis (Endometriosis of uterus)

0.00

0.0

1.1

—

Alzheimer’s disease, wide definition

0.00

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

Benign mammary dysplasia

0.00

0.0

1.1

—

Sleep disorders, other/unspecified

0.00

0.0

3.6

—

Other disorders of pigmentation

0.00

0.0

4.6

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

2.6

—

Other bursopathies

0.00

0.0

2.3

—

Constitutional tall stature

0.00

0.0

4.4

—

Recurrent dislocation and subluxation of joint

0.00

0.0

1.4

—

Rheumatism, unspecified

0.00

0.0

1.0

—

Congenital malformations of great veins

0.00

0.0

6.3

—

Uterine polyps

0.00

0.0

1.2

—

Polyarthrosis

0.00

0.0

1.3

—

Spermatocele

0.00

0.0

2.3

—

Obesity and other hyperalimentation

0.92

0.00

1.9

3.2

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.0

5.8

—

L02BA Anti-estrogens

0.00

0.0

1.3

—

Psychotic depression

0.00

0.0

1.9

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

6.8

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.0

1.1

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.8

—

Memory loss

0.00

0.0

1.0

—

Obesity

0.93

0.00

1.9

3.2

—

Ovarian dysfunction

0.00

0.0

2.2

—

Graves disease, strict definition

0.00

0.0

1.0

—

Poor fetal growth

0.00

0.0

1.6

—

Polycystic ovarian syndrome, broad definition

0.00

0.0

1.2

—

N06DA Anticholinesterases

0.00

0.0

1.1

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.0

5.1

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

2.2

—

Temporomandibular joint disorders, including avohilmo

0.94

0.00

1.3

2.4

—

Other obstructed labour

0.00

0.0

1.3

—

Other perinatal digestive system disorders

0.00

0.0

6.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

2.0

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

4.3

—

0.00

-0.00

0.0

6.1

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS